Consumption of Refined Sugar by Patients with Crohn's Disease, Ulcerative Colitis, or Irritable Bowel Syndrome

Publisher Website
Google Scholar
Abstract
The daily dietary consumption of refined sugar was studied in 4 equal-sized groups of 30 patients with Crohn''s disease, ulcerative colitis (UC), irritable bowel syndrome (IBS) or minor orthopedic conditions. The latter group was matched for sex and age with the Crohn''s disease group. The Crohn''s disease patients consumed significantly more refined sugar (88.9 .+-. 50.7 (SD) g/day) than the controls (64.3 .+-. 45.6 g/day), the UC patients (64.3 .+-. 38.7) or the IBS patients (59.9 .+-. 33.3). Fifteen patients with Crohn''s disease interviewed within 6 mo. of diagnosis consumed similar amounts of sugar (69.9 .+-. 43.9) to those of the subjects in the other 3 groups. Fifteen other patients with Crohn''s disease studied 7-36 mo. after diagnosis consumed significantly more refined sugar (107.9 .+-. 51.2). The high sugar consumption in Crohn''s disease is a secondary phenomenon without etiologic importance.